Form D · Venture Capital Fund

Windham Life Sciences Partners IV, L.P.

New York, NY · CIK 0001999637

Offering snapshot reported Nov 9, 2026 · SEC filing

Reported sold
$58.6M
Offering amount: $200M
Investors reported
83
Form D · investor count
Minimum accepted
$1
Reported outside-investor minimum
First sale
Oct 27, 2023
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$29.3M$58.6MNov 3, 2023: $1,250,000.00Nov 3, 2023Nov 8, 2023: $1,250,000.00Nov 15, 2024: $19,525,000.00Nov 15, 2024Nov 13, 2025: $30,784,955.00Nov 13, 2025Nov 9, 2026: $58,625,000.00Nov 9, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$30,784,955 → $58,625,000
  • Reported investors51 → 83

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 9, 2026Amendment$58,625,000$27,840,045vs Nov 13, 202583SEC filing
Nov 13, 2025Amendment$30,784,955$11,259,955vs Nov 15, 202451SEC filing
Nov 15, 2024Amendment$19,525,000$18,275,000vs Nov 8, 202332SEC filing
Nov 8, 2023Amendment$1,250,000$0vs Nov 3, 20233SEC filing
Nov 3, 2023Initial$1,250,000No comparison3SEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
06b, 3C, 3C.1, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$210K
Finders' fees
$0
Form D file number
021-496484

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
WAVECREST SECURITIES LLC160135

Source: Form D, filed Nov 9, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Adam E Fine Executive, Promoter
Adam E Windham Life Sciences Partners General Partner Iv, Llc Promoter
Windham Life Sciences Partners General Partner Iv, Llc Director

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
500 Fifth Avenue Suite #3600
New York, NY, 10110